Literature DB >> 12392272

Metabolic and hemodynamic effects of hypertonic solutions: sodium-lactate versus sodium chloride infusion in postoperative patients.

Iqbal Mustafa1, Xavier M Leverve.   

Abstract

Although hypertonic saline has been proposed as an intravenous resuscitation fluid, the beneficial effects of the sodium load are associated with potentially deleterious effects of chloride. Since the physiological lactate anion is well metabolized, hypertonic lactate solution could represent an interesting alternative. The aim of this study was to compare metabolic and hemodynamic effects of hypertonic infusion of sodium lactate versus sodium chloride in three groups of surgical patients who underwent elective coronary artery bypass grafting (CABG). Hypertonic lactate solution was infused to patients 14 to 16 h after surgery either involving a cardiopulmonary bypass (CPB-Lac, n = 20) or on-off pump (OPCAB-Lac, n = 20), whereas the third group consisted of patients undergoing cardiopulmonary bypass but receiving hypertonic saline solution (CPB-NaCl, n = 20). An equal fluid and sodium load (2.5 mL/2.5 mmol x kg(-1)) was infused in all patients over 15 min. Plasma glucose and sodium increased after infusion in the three groups, but the changes, although significant, were small. As expected, lactate rose only in CPB-Lac and OPCAB-Lac groups, the changes being more marked in CPB-Lac, indicating a slower lactate metabolism in this group compared with OPCAB-Lac. Although both solutions produced significant increases in cardiac index and oxygen delivery, there was a significant decrease in oxygen extraction only in groups receiving sodium lactate (CPB-Lac and OPCAB-Lac) and not in CPB-NaCl. Finally, hypertonic NaCl infusion induced a modest, although significant, decrease in arterial pH and bicarbonate, whereas hypertonic lactate infusion increased these two parameters in both CPB-Lac and OPCAB-Lac. This study demonstrates that hypertonic lactate infusion is safe and well tolerated in patients undergoing elective cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12392272     DOI: 10.1097/00024382-200210000-00003

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  22 in total

1.  Hidden evidence to the West: multicentre, randomised, controlled trials in sepsis and systemic inflammatory response syndrome in Japanese journals.

Authors:  Rinaldo Bellomo; Shigehiko Uchino; Toshio Naka; Li Wan
Journal:  Intensive Care Med       Date:  2004-03-30       Impact factor: 17.440

2.  Lactate in shock: a high-octane fuel for the heart?

Authors:  Martin Matejovic; Peter Radermacher; Eric Fontaine
Journal:  Intensive Care Med       Date:  2007-01-23       Impact factor: 17.440

3.  Hypertonic lactate solutions: a new horizon for fluid resuscitation?

Authors:  Florian Wagner; Peter Radermacher; Hiroshi Morimatsu
Journal:  Intensive Care Med       Date:  2008-06-18       Impact factor: 17.440

4.  Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients.

Authors:  Carole Ichai; Guy Armando; Jean-Christophe Orban; Frederic Berthier; Laurent Rami; Corine Samat-Long; Dominique Grimaud; Xavier Leverve
Journal:  Intensive Care Med       Date:  2008-09-20       Impact factor: 17.440

5.  The Stewart approach--one clinician's perspective.

Authors:  T John Morgan
Journal:  Clin Biochem Rev       Date:  2009-05

6.  The impact of increased blood lactate on serum S100B and prolactin concentrations in male adult athletes.

Authors:  Stefanie Schulte; Thorsten Schiffer; Billy Sperlich; Axel Knicker; Leslie W Podlog; Heiko K Strüder
Journal:  Eur J Appl Physiol       Date:  2012-09-29       Impact factor: 3.078

7.  Myocardial lactate deprivation is associated with decreased cardiovascular performance, decreased myocardial energetics, and early death in endotoxic shock.

Authors:  Bruno Levy; Arnauld Mansart; Chantal Montemont; Sebastien Gibot; Jean-Pierre Mallie; Veronique Regnault; Thomas Lecompte; Patrick Lacolley
Journal:  Intensive Care Med       Date:  2007-01-23       Impact factor: 17.440

8.  No influence of ischemic preconditioning on running economy.

Authors:  Gungeet Kaur; Megan Binger; Claire Evans; Tiffany Trachte; Gary P Van Guilder
Journal:  Eur J Appl Physiol       Date:  2016-12-23       Impact factor: 3.078

9.  Half-molar sodium lactate infusion to prevent intracranial hypertensive episodes in severe traumatic brain injured patients: a randomized controlled trial.

Authors:  Carole Ichai; Jean-François Payen; Jean-Christophe Orban; Hervé Quintard; Hubert Roth; Robin Legrand; Gilles Francony; Xavier M Leverve
Journal:  Intensive Care Med       Date:  2013-06-08       Impact factor: 17.440

10.  Half-molar sodium-lactate solution has a beneficial effect in patients after coronary artery bypass grafting.

Authors:  Xavier M Leverve; Cindy Boon; Tarmizi Hakim; Maizul Anwar; Erwin Siregar; Iqbal Mustafa
Journal:  Intensive Care Med       Date:  2008-06-18       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.